Treatment of oestrogen deficiency in women with previous breast cancer

Abstract

Get full access to this article

View all access options for this article.

References

Carpenter

, Andykowski

, Cordova

Hot flashes in postmenopausal women treated for breast carcinoma.

Cancer 1998; 82: 1682-91.

Quella

, Loprinzi

, Barton

Evaluation of soy phytoestrogens for treatment of hot flashes in breast cancer survivors.

J Clin Oncol 1999; 18: 1068-74.

Quella

, Loprinzi

, Sloan

Long-term use of megestrol acetate by cancer survivors for the treatment of hot flashes.

Cancer 1998; 82: 1784-88.

Ginsburg

, Prelevic

. Tibolone in postmenopausal women with a history of breast carcinoma. J Br Menopause Soc 1995; 1: 24-25.

Collaborative Group on Hormonal Factors for Breast Cancer.

Breast cancer and hormone replacement therapy: Collaborative reanalysisfrom 51 individual epidemiological studies.

Lancet 1997; 350: 1047-60.

Willis

, Calle

, Miracle-McMahill

, Heath

. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States. Cancer Causes and Control 1996; 7: 449-57.

Vassilopoulou-Sellin

, Asmar

, Hortobagyi

Estrogen replacement therapy after local breast cancer: Clinical outcome of 319 women following prospectively.

J Clin Oncol 1999; 17: 1482-87.

Consensus Statement.

Treatment of estrogen deficiency symptoms in women surviving breast cancer.

J Clin Endocrin Metab 1998; 83: 1993-2000.

Marsden

, Sacks

NPM

Baum

Are randomised trials of hormone replacement therapy in symptomatic breast cancer patients feasible?

Fertil Steril 2000; 73: 292-99.